Live
Webinar

Strong at 35 and Sharp at 50: Here's the Longevity Evidence

Speakers

Sara Szal, MD

November 19, 2026
2 PM EST

Ovarian aging begins earlier than many other organ systems, and emerging research suggests it may be an early contributor to systemic aging in women, not just a potential downstream effect. It may involve mitochondrial decline and inflammaging, and coincide with loss of muscle mass, often years before the diagnosis of perimenopause itself. This webinar walks practitioners through recent science connecting ovarian reserve, AMH trends, and systemic aging biology, then translates it into practice for patients in the ages 35–50+ window. Dr. Sara Szal, MD, covers the mechanisms linking reproductive aging to broader longevity outcomes, and how targeted nutrient support for muscle and bone, alongside emerging research on cellular senescence, may support a patient's trajectory before symptoms appear.

Key takeaways

  • Learn the evidence suggesting ovarian aging may be an early contributor to systemic aging in women, rather than only a downstream consequence of it.
  • Understand the mechanistic role of mitochondrial decline and inflammaging within the aging ovary, including the contributions of reactive oxygen species and mitochondrial DNA damage.
  • Identify the inflammatory pathways implicated in ovarian aging, including cGAS-STING and NLRP3 inflammasome activation, and their proposed link to accelerated biological aging.
  • Interpret AMH, estradiol, and FSH trends and other ovarian reserve markers in the context of reproductive aging and their potential associations with systemic aging biology for patients in the ages 35–50+ window.
  • Apply nutrient-based strategies, including protein, foundational greens, and perimenopause-targeted hormone support, to support healthy aging during this decade.